United States Government Publishing Office publisher pbl distributor dst United States Congress Senate author aut Government Organization text government publication eng BILLS To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.;Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019;Over-the-Counter Monograph User Fee Act of 2019;S. 2740 (RS) Bills and Statutes 116_cong_bills legislative 2019-11-06 U.S. Government Publishing Office 2019-11-05 monographic deposited born digital 98 p. Y 1.6: Y 1.4/1: P0b002ee1a383780c https://www.govinfo.gov/app/details/BILLS-116s2740rs S. 2740 021-610-00252-9 000501532 000325576 Congressional bills Senate bills f:s2740_rs.txt https://www.govinfo.gov/app/details/BILLS-116s2740rs https://www.govinfo.gov/content/pkg/BILLS-116s2740rs/html/BILLS-116s2740rs.htm https://www.govinfo.gov/content/pkg/BILLS-116s2740rs/pdf/BILLS-116s2740rs.pdf https://www.govinfo.gov/content/pkg/BILLS-116s2740rs/xml/BILLS-116s2740rs.xml fdlp DGPO 2019-11-06 2023-01-01 BILLS-116s2740rs machine generated eng Johnny Isakson United States Senate sponsor spn United States Congress Member Robert P. Casey Jr. United States Senate cosponsor United States Congress Member Mike Braun United States Senate cosponsor United States Congress Member United States Congress Senate Committee on Health, Education, Labor, and Pensions associated name asn Title 5 Section 552(b)(4) Title 5 Section 553 Title 5 Chapter 5 5 U.S.C. 552(b)(4) 5 U.S.C. 553 5 U.S.C. Chapter 5 Title 18 Section 1905 18 U.S.C. 1905 Title 21 Section 301et seq. Title 21 Section 352 Title 21 Section 355 Title 21 Section 355g Title 21 Section 360fff-3 Title 21 Section 360fff-3(b) Title 21 Section 360fff-3(e) Title 21 Section 360fff-5 Title 21 Section 360fff-6 Title 21 Section 360fff Title 21 Section 360fffet seq. Title 21 Section 379fet seq. Title 21 Section 379r(d)(1) Title 21 Section 381(e)(4)(E)(iii) 21 U.S.C. 301et seq. 21 U.S.C. 352 21 U.S.C. 355 21 U.S.C. 355g 21 U.S.C. 360fff-3 21 U.S.C. 360fff-3(b) 21 U.S.C. 360fff-3(e) 21 U.S.C. 360fff-5 21 U.S.C. 360fff-6 21 U.S.C. 360fff 21 U.S.C. 360fffet seq. 21 U.S.C. 379fet seq. 21 U.S.C. 379r(d)(1) 21 U.S.C. 381(e)(4)(E)(iii) Title 31 Chapter 37 31 U.S.C. Chapter 37 Title 44 Chapter 35 44 U.S.C. Chapter 35 Public Law 115-52 Senate Calendar No. 290 s BILLS-116s2740rs 116 1 SENATE SENATE 2740 rs rs Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 Over-the-Counter Monograph User Fee Act of 2019 To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes. Reported by Mr. Alexander, without amendment Mr. Isakson (for himself, Mr. Casey, and Mr. Braun) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions Committee on Health, Education, Labor, and Pensions Health, Education, Labor, and Pensions Mr. Isakson Johnny Isakson Isakson, Johnny Mr. Casey Robert P. Casey Jr. Casey, Robert P., Jr. Mr. Bob Casey Jr. Mr. Braun Mike Braun Braun, Mike false false